Morning Overview on MSN
FDA clears first US trial of Motif’s wireless brain implant for depression
A coin-sized device with no battery, no wires, and no deep surgical penetration into the brain just cleared its biggest ...
A wireless brain implant for treatment-resistant depression has received FDA clearance for human trials in the United States.
A new research paper argues that emerging brain–computer interface (BCI) technologies are not just medical tools but ...
The same fully implanted, wireless device supporting motor recovery after stroke now enables thought-controlled computer use ...
MintNeuro, a pioneer of scalable, low-power semiconductor technology for neural implant applications, and Motif Neurotech, a therapeutic brain-computer interface (BCI) company developing miniature ...
By integrating sub-50ms end-to-end latency with BCI-driven functional electrical stimulation (BCI-FES), the system enables a ...
The FDA has authorized the first human trial of a brain-computer interface designed to treat severe, treatment-resistant depression. Created by Motif Neurotech, the small implant works with a wireless ...
A research team has published details of a brain-computer interface that abandons the conventional approach of ...
Highly anticipated: As the brain-computer interface technology field transitions from experimental demonstrations to practical clinical applications, the University of Michigan has just achieved a ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
ANN ARBOR, MI -- One of the first brain-computer interface clinics in the country has opened in Ann Arbor. University of Michigan Health opened its clinic to patients with severe motor and speech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results